Concepedia

Jon E. Stek

JE

Statistics

Publications

36

Citations

2K

H-Index

27

Active since

2006

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Tampere University

University of Colorado Denver

Jon E. Stek is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in veterinary medicine, vaccinology, and vaccination.

ORCID

Publications per year

2006–2023

36

Publications

36

Efficacy, Safety, and Tolerability of Herpes Zoster Vaccine in Persons Aged 50-59 Years

Ken Schmader, Myron J. Levin, J. W. Gnann et al. · Clinical Infectious Diseases · 2012 · 431 citations · Full text

, , +17

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants

David Greenberg, Patricia Hoover, Timo Vesikari et al. · Vaccine · 2018 · 107 citations

, , +14

Safety and Immunogenicity Profile of the Concomitant Administration of ZOSTAVAX and Inactivated Influenza Vaccine in Adults Aged 50 and Older

Boris Kerzner, Alexander V. Murray, Rudy Ifle et al. · Journal of the American Geriatrics Society · 2007 · 96 citations

, , +17

Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial

Drew J. Winston, Kathleen M. Mullane, Oliver A. Cornely et al. · The Lancet · 2018 · 96 citations

, , +16

Safety and Immunogenicity of Heat-Treated Zoster Vaccine (ZVHT) in Immunocompromised Adults

Kathleen M. Mullane, Drew J. Winston, M. S. Wertheim et al. · The Journal of Infectious Diseases · 2013 · 78 citations · Full text

, , +16

1–5 of 36